Preclinical Safety Evaluation of a Recombinant Plasmid Vector Encoding Mature Human Neutrophil Peptide-1 by Repeated Local Administrations in Nonhuman Primates-Reference-Cited by-同舟云学术

Preclinical Safety Evaluation of a Recombinant Plasmid Vector Encoding Mature Human Neutrophil Peptide-1 by Repeated Local Administrations in Nonhuman Primates

Published:2021-08-09 Issue: Volume: Page:
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Li Dan¹,Guo Fuchun²,Chen Ke³,Yang Xunning³,Wang Yongsheng²⁴^ORCID

Affiliation:

1. Institute of Respiratory Health, Frontiers Science Center for Disease-Related Molecular Network, and Precision Medicine Center, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China.

2. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

3. WestChina-Frontier Pharma Tech Co., Ltd. (WCFP), National Chengdu Center for Safety Evaluation of Drugs (NCCSED), Chengdu, China.

4. Institute of Drug Clinical Trial, West China Hospital, Sichuan University, Chengdu, China.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2020.289

Reference31 articles.

1. α‐Defensin Inhibits Influenza Virus Replication by Cell‐Mediated Mechanism(s)

2. Defensins: antimicrobial peptides of innate immunity

3. Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study

4. Human α-Defensins HNPs-1, -2, and -3 in Renal Cell Carcinoma

5. Identification and overexpression of human neutrophil α-defensins (human neutrophil peptides 1, 2 and 3) in squamous cell carcinomas of the human tongue

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Viral Vectors for Delivery of Nucleic Acid Therapies for Cancer;BioTech;2022-03-07